193 related articles for article (PubMed ID: 33228665)
1. Irreversible electroporation in patients with liver tumours: treated-area patterns with contrast-enhanced ultrasound.
Zhou L; Yin S; Chai W; Zhao Q; Tian G; Xu D; Jiang T
World J Surg Oncol; 2020 Nov; 18(1):305. PubMed ID: 33228665
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound and Contrast-enhanced Ultrasound Findings after Percutaneous Irreversible Electroporation of Hepatic Malignant Tumors.
Chai W; Xie L; Zhao Q; Cheng C; Tian G; Jiang T; Wu P
Ultrasound Med Biol; 2020 Mar; 46(3):620-629. PubMed ID: 31924420
[TBL] [Abstract][Full Text] [Related]
3. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous irreversible electroporation of hepatocellular carcinoma: Contrast-enhanced ultrasound-findings during 1-year follow-up.
Niessen C; Beyer LP; Haimerl M; Schicho A; Stroszczynski C; Wiggermann P; Jung EM
Clin Hemorheol Microcirc; 2019; 72(1):85-93. PubMed ID: 30584122
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound and Contrast-Enhanced Ultrasound for Evaluation of Irreversible Electroporation Ablation: In Vivo Proof of Concept in Normal Porcine Liver.
Lin MX; Kuang M; Xu M; Zhuang BW; Tian WS; Ye JY; Xie XH; Xie XY
Ultrasound Med Biol; 2016 Nov; 42(11):2639-2649. PubMed ID: 27546157
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous irreversible electroporation (IRE) of hepatic malignant tumours: contrast-enhanced ultrasound (CEUS) findings.
Wiggermann P; Zeman F; Niessen C; Agha A; Trabold B; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2012; 52(2-4):417-27. PubMed ID: 22986756
[TBL] [Abstract][Full Text] [Related]
7. MRI and contrast-enhanced ultrasound imaging for evaluation of focal irreversible electroporation treatment: results from a phase I-II study in patients undergoing IRE followed by radical prostatectomy.
van den Bos W; de Bruin DM; van Randen A; Engelbrecht MR; Postema AW; Muller BG; Varkarakis IM; Skolarikos A; Savci-Heijink CD; Jurhill RR; Zondervan PJ; Laguna Pes MP; Wijkstra H; de Reijke TM; de la Rosette JJ
Eur Radiol; 2016 Jul; 26(7):2252-60. PubMed ID: 26449559
[TBL] [Abstract][Full Text] [Related]
8. Multimodality imaging to assess immediate response following irreversible electroporation in patients with malignant hepatic tumors.
Sugimoto K; Moriyasu F; Saito K; Kobayashi Y; Itoi T
J Med Ultrason (2001); 2017 Jul; 44(3):247-254. PubMed ID: 27933441
[TBL] [Abstract][Full Text] [Related]
9. Color Coded Perfusion Imaging with Contrast Enhanced Ultrasound (CEUS) for Post-Interventional Success Control Following Irreversible Electroporation (IRE) of Primary and Secondary Malignant Liver Lesions.
Rennert J; Wiesinger I; Schicho A; Wiggermann P; Stroszczynski C; Beyer LP; Jung EM
J Gastrointestin Liver Dis; 2019 Sep; 28(3):311-318. PubMed ID: 31517328
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous irreversible electroporation (IRE) of prostate cancer: Contrast-enhanced ultrasound (CEUS) findings during follow up.
Beyer LP; Pregler B; Nießen C; Michalik K; Haimerl M; Stroszczynski C; Jung EM; Wiggermann P
Clin Hemorheol Microcirc; 2016; 64(3):501-506. PubMed ID: 27935553
[TBL] [Abstract][Full Text] [Related]
11. MR and CT imaging characteristics and ablation zone volumetry of locally advanced pancreatic cancer treated with irreversible electroporation.
Vroomen LGPH; Scheffer HJ; Melenhorst MCAM; de Jong MC; van den Bergh JE; van Kuijk C; van Delft F; Kazemier G; Meijerink MR
Eur Radiol; 2017 Jun; 27(6):2521-2531. PubMed ID: 27659702
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous irreversible electroporation (IRE) of prostate cancer: Contrast-enhanced ultrasound (CEUS) findings.
Niessen C; Jung EM; Beyer L; Pregler B; Dollinger M; Haimerl M; Scheer F; Stroszczynski C; Wiggermann P
Clin Hemorheol Microcirc; 2015; 61(2):135-41. PubMed ID: 26410867
[TBL] [Abstract][Full Text] [Related]
13. Ablation of colorectal liver metastases by irreversible electroporation: results of the COLDFIRE-I ablate-and-resect study.
Scheffer HJ; Nielsen K; van Tilborg AA; Vieveen JM; Bouwman RA; Kazemier G; Niessen HW; Meijer S; van Kuijk C; van den Tol MP; Meijerink MR
Eur Radiol; 2014 Oct; 24(10):2467-75. PubMed ID: 24939670
[TBL] [Abstract][Full Text] [Related]
14. Contrast enhanced ultrasound (CEUS) with parametric imaging after irreversible electroporation (IRE) of the prostate to assess the success of prostate cancer treatment.
Jung EM; Engel M; Wiggermann P; Schicho A; Lerchbaumer M; Stroszczynski C; Fischer T; Wiesinger I
Clin Hemorheol Microcirc; 2021; 77(3):303-310. PubMed ID: 33337354
[TBL] [Abstract][Full Text] [Related]
15. Comparison between high-frequency irreversible electroporation and irreversible electroporation ablation of small swine liver: follow-up of DCE-MRI and pathological observations.
Li J; Zhang XB; Wang JJ; Jin LJ; Shan HS; Zhang X; Ma L; Xue XD; Zhang X; Zhang ZL; Meng LL; Yuan F; Xiao YY
Chin Med J (Engl); 2021 Jun; 134(17):2081-2090. PubMed ID: 34172620
[TBL] [Abstract][Full Text] [Related]
16. Transcatheter intra-arterial perfusion (TRIP)-MRI biomarkers help detect immediate response to irreversible electroporation of rabbit VX2 liver tumor.
Figini M; Zhou K; Pan L; Sun C; Wang B; Hu S; Yang J; Shangguan J; Eresen A; Velichko Y; Yaghmai V; Zhang Z
Magn Reson Med; 2020 Jul; 84(1):365-374. PubMed ID: 31850550
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound-guided percutaneous irreversible electroporation of hepatic and abdominal tumors not eligible for surgery or thermal ablation: a western report on safety and efficacy.
Giorgio A; Amendola F; Calvanese A; Ingenito E; Santoro B; Gatti P; Ciracì E; Matteucci P; Giorgio V
J Ultrasound; 2019 Mar; 22(1):53-58. PubMed ID: 30843171
[TBL] [Abstract][Full Text] [Related]
18. Irreversible electroporation for the treatment of localized prostate cancer: a summary of imaging findings and treatment feedback.
Scheltema MJ; Postema AW; de Bruin DM; Buijs M; Engelbrecht MR; Laguna MP; Wijkstra H; de Reijke TM; de la Rosette JJMCH
Diagn Interv Radiol; 2017; 23(5):365-370. PubMed ID: 28830850
[TBL] [Abstract][Full Text] [Related]
19. Irreversible electroporation in the liver: contrast-enhanced inversion-recovery MR imaging approaches to differentiate reversibly electroporated penumbra from irreversibly electroporated ablation zones.
Guo Y; Zhang Y; Nijm GM; Sahakian AV; Yang GY; Omary RA; Larson AC
Radiology; 2011 Feb; 258(2):461-8. PubMed ID: 21131581
[TBL] [Abstract][Full Text] [Related]
20. Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.
Dollinger M; Müller-Wille R; Zeman F; Haimerl M; Niessen C; Beyer LP; Lang SA; Teufel A; Stroszczynski C; Wiggermann P
PLoS One; 2015; 10(8):e0135773. PubMed ID: 26270651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
